Working…
ClinicalTrials.gov
ClinicalTrials.gov Menu

Study of Crizotinib for ROS1 and MET Activated Lung Cancer

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details.
 
ClinicalTrials.gov Identifier: NCT04084717
Recruitment Status : Recruiting
First Posted : September 10, 2019
Last Update Posted : April 1, 2021
Sponsor:
Collaborator:
Pfizer
Information provided by (Responsible Party):
University Health Network, Toronto

No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : Recruiting
Estimated Primary Completion Date : December 2024
Estimated Study Completion Date : June 2025